CWM
Concentric Wealth Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.36M | Hold |
46,526
| – | – | 0.33% | 66 |
|
|
2024
Q2 | $1.08M | Buy |
46,526
+10,040
| +28% | +$233K | 0.28% | 69 |
|
|
2024
Q1 | $749K | Hold |
36,486
| – | – | 0.2% | 82 |
|
|
2023
Q4 | $783K | Hold |
36,486
| – | – | 0.23% | 78 |
|
|
2023
Q3 | $753K | Hold |
36,486
| – | – | 0.25% | 78 |
|
|
2023
Q2 | $1.08M | Hold |
36,486
| – | – | 0.34% | 69 |
|
|
2023
Q1 | $841K | Buy |
36,486
+8,519
| +30% | +$196K | 0.28% | 72 |
|
|
2022
Q4 | $778K | Hold |
27,967
| – | – | 0.27% | 74 |
|
|
2022
Q3 | $858K | Hold |
27,967
| – | – | 0.32% | 73 |
|
|
2022
Q2 | $823K | Hold |
27,967
| – | – | 0.28% | 74 |
|
|
2022
Q1 | $900K | Hold |
27,967
| – | – | 0.26% | 78 |
|
|
2021
Q4 | $1.25M | Hold |
27,967
| – | – | 0.35% | 73 |
|
|
2021
Q3 | $1.41M | Buy |
27,967
+8,621
| +45% | +$435K | 0.43% | 69 |
|
|
2021
Q2 | $1.52M | Sell |
19,346
-5,092
| -21% | -$400K | 0.46% | 69 |
|
|
2021
Q1 | $1.4M | Sell |
24,438
-1,713
| -7% | -$97.8K | 0.46% | 70 |
|
|
2020
Q4 | $2.19M | Buy |
26,151
+5,000
| +24% | +$419K | 0.81% | 49 |
|
|
2020
Q3 | $758K | Sell |
21,151
-3,000
| -12% | -$108K | 0.33% | 72 |
|
|
2020
Q2 | $584K | Hold |
24,151
| – | – | 0.27% | 77 |
|
|
2020
Q1 | $423K | Buy |
+24,151
| New | +$423K | 0.23% | 80 |
|